Adicet Bio Presents Scientific Biomarker Information for Off-the-Shelf CAR T Cell Remedy in an Oral Session on the American Faculty of Rheumatology (ACR) Convergence 2024 By Investing.com
-Information exhibit traits important for therapy of autoimmune illnesses, together with strong…
Travere Therapeutics Presents Knowledge Reinforcing Scientific Advantage of FILSPARI ® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024 By Investing.com
Practically 60% of sufferers with IgAN within the SPARTAN Research achieved full…
Europe falls behind China in taking part in host to scientific drug trials
Keep knowledgeable with free updatesMerely signal as much as the Prescription drugs…
Foresee Prescribed drugs Proclaims Preliminary Outcomes from a Part 1 Scientific Trial, Highlighting Promising Security, Tolerability and Pharmacokinetic Profile of Linvemastat (FP-020), a Novel and Choose By Investing.com
TAIPEI, Oct. 20, 2024 /PRNewswire/ -- Foresee Prescribed drugs (TPEx: 6576), ("Foresee")…
Citi lifts Akeso inventory goal with Purchase ranking on robust medical information By Investing.com
Citi has elevated its value goal for Akeso Inc (9926: HK) shares…
Research outcomes from section 1 research with exidavnemab printed in The Journal of Medical Pharmacology By Investing.com
STOCKHOLM, Aug. 27, 2024 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA…
Fujitsu tackles ‘drug loss’ in Japan by means of ecosystem to speed up digitalization of medical trials By Investing.com
KAWASAKI, Japan, Aug 26, 2024 - (JCN Newswire) - - Fujitsu at…
BerGenBio Second Quarter Outcomes 2024: Strong medical and monetary progress By Investing.com
BERGEN, Norway, Aug. 21, 2024 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a…
Bioretec Ltd’s half-year report January-June 2024: RemeOs™ trauma screw managed launch within the U.S. yielded anticipated constructive medical outcomes By Investing.com
Bioretec Ltd Firm announcement 15 August 2024 at 8:00 a.m. TAMPERE,…
